Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis
NCT01158183
·
clinicaltrials.gov ↗
COMPLETED
Status
226
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG:
BAY86-5046_Interferon-beta-1b
Sponsor
Bayer